Patents for C12P 21 - Preparation of peptides or proteins (112,499)
07/2007
07/25/2007EP0665888B2 Ryegrass pollen allergen
07/25/2007CN1328381C GnRH-leukotoxin chimeras
07/25/2007CN1328286C Aglyco products and method of use
07/25/2007CN101006177A An improved method for synthesising templated molecules
07/25/2007CN101003829A Polypeptide of seed of spine date, preparation method, and application
07/25/2007CN101003828A Method of producing bioactive peptide for anti high blood pressure by using protease of Switzerland lactobacillus to hydrolyze lactoprotein
07/25/2007CN101003827A Method for preparing bioactive peptide of collagen from squid skin, and application
07/25/2007CN101003826A Method for preparing laver polypeptide based on pretreatment of ultrasonic
07/25/2007CN101003817A Natural melanin synthesized by enzyme method
07/25/2007CN101003806A Method for expressing metallothionein of human by using body of vegetable oil
07/25/2007CN101003802A Method for preparing maturation peptide of morphogenesis protein ¿C 2 of human bones
07/25/2007CN101003573A Human antibodies that bind human tnfalpha
07/25/2007CN101002936A Vaccine for preventing flavivirus infection
07/25/2007CN101002933A Honeysuckle polypeptide, its preparing method and use
07/25/2007CN101002932A Tuckahoe polypeptide, its preparing method and use
07/25/2007CN101002549A Transgenic non-human animals capable of producing heterologous antibodies
07/24/2007US7247717 Polynucleotide encoding a novel human serpin secreted from lymphoid cells, LSI-01
07/24/2007US7247715 Ricin-like toxin variants for treatment of cancer, viral or parasitic infections
07/24/2007US7247714 DNA sequences found in the regulatory region of cytoprotective genes that are cytoprotective response elements
07/24/2007US7247711 For therapy or reducing the symptoms of immune, neurological, and related disorders, such as, but not limited to, multiple sclerosis, rheumatoid arthritis, juvenile rheumatoid arthritis, systemic onset juvenile rheumatoid arthritis, psoriatic arthritis, ankylosing spondilitis, gastric ulcer
07/24/2007US7247709 Mitogenic oxygenases
07/24/2007US7247703 Anticancer agents; protein complex
07/24/2007US7247615 Nucleic acid encoding peptides which antagonist epitope against prostate specific antigen; anticancer agents
07/24/2007US7247613 Comprises expression vector coding insecticidal polypeptide for use in generation and propagation of insect resistant plants; boiological pest control
07/24/2007US7247612 novel cell surface molecules of mammals
07/24/2007US7247608 FGF homolog polypeptides
07/24/2007US7247502 Nicotine hapten that is nicotine in which the pyrrolidine ring is substituted by an omega-carboxy-, -amino-, -formyl- or -mercapto-alkyl group; useful in formulating vaccines for active immunization
07/24/2007US7247476 Isolated monoclonal antibody; patient specific anti-cancer antibodies using a novel paradigm of screening
07/24/2007US7247475 Optimizing the expression level of an antibody producing eukaryotic host cells capable of expressing a first DNA sequence encoding an antibody heavy chain or an antigen binding portion, culturing host cells, amplifying, choosing a host cell that produces a desired amount of antibody
07/24/2007US7247472 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
07/24/2007US7247466 Amino acid racemase having low substrate specificity and process for producing racemic amino acid
07/24/2007US7247463 Enzymes with lipase/acyltransferase activity, nucleic acids encoding the same and methods of use thereof
07/24/2007US7247461 Nucleic acid molecule encoding ORFA of a PUFA polyketide synthase system and uses thereof
07/24/2007US7247460 Thermostable omega-transaminases
07/24/2007US7247454 Methods for recombinant peptide production
07/24/2007US7247453 Calcium binding recombinant antibody against protein C
07/24/2007US7247450 Secretion, transcription and sporulation genes in Bacillus clausii
07/24/2007US7247449 Fluorescent protein
07/24/2007US7247448 Method for gene expression
07/24/2007US7247447 Methods to obtain and use such proteins, antibodies, and inhibitory compounds; treating flea infestations in animals; biological pest control
07/24/2007US7247446 PRO34128 nucleic acids
07/24/2007US7247441 Nucleic acid sequence and protein in addition to polypeptides coding for mannitol dehydrogenases or parts thereof and the production and use thereof in diagnosis and therapy
07/24/2007US7247436 Mutations in the KCNE1 gene encoding human minK which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT gene
07/24/2007US7247308 Vaccine; polynucleotide; generating antibodies
07/24/2007US7247306 Bacteria strain and bacteriocin produced therefrom
07/24/2007US7247301 Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
07/24/2007CA2246429C Erbb3 antibodies
07/24/2007CA2162134C Hepatitis-c virus type 4,5 and 6
07/24/2007CA2151236C Stably transfected cell lines expressing gaba-a receptors
07/24/2007CA2121798C Novel cytokine
07/24/2007CA1341536C Transforming growth factor peptides
07/23/2007CA2637947A1 Production of proteins carrying oligomannose or human-like glycans in yeast and methods of use thereof
07/19/2007WO2007081943A2 Methods and compositions for promoting attachment of cells of endothelial cell lineage to medical devices
07/19/2007WO2007081942A2 Compositions and methods for promoting attachment of cells of endothelial cell lineage to medical devices
07/19/2007WO2007081647A2 Zinc finger domains specifically binding agc
07/19/2007WO2007081534A2 Method of producing catalytically active bace2 enzymes
07/19/2007WO2007081307A1 A method for inclusion of psychological temperament in an electornic emulation of the human brain
07/19/2007WO2007080847A1 Mutant growth factor with altered receptor specificity and pharmaceutical composition containing the same
07/19/2007WO2007080277A1 Method for preparing antibodies selective for activating fc receptors
07/19/2007WO2007079546A1 PHOSPHORYLATED Sp1 ANTIBODIES
07/19/2007WO2006009938A3 Genetically purified gellan gum
07/19/2007WO2005012492A3 Human skin equivalents expressing exogenous polypeptides
07/19/2007WO2003035847A3 Il-13 mutein proteins, antibodies, compositions, methods and uses
07/19/2007US20070169223 protein purification of high-value heterologous proteins produced in plants, plant derived tissue or plant cells; non-denaturing
07/19/2007US20070169221 Novel Bt toxin receptors from lepidopteran insects and methods of use
07/19/2007US20070169211 Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof
07/19/2007US20070169208 Silkworm strains for enabling production of proteins using various baculovirus
07/19/2007US20070167610 Recombinant soluble adenovirus receptor
07/19/2007US20070167607 Use of soluble forms of cd83 and nucleic acids encoding them for the treatment or prevention of diseases
07/19/2007US20070167372 Ocular tear growth factor-like protein
07/19/2007US20070167371 Treating deficient tear output and enhancing the proliferation of human corneal epithelial cells by contacting the ocular surface or the cells with a lacrimal gland protein that has activity as a growth factor on both human corneal epithelial cells and on the lacrimal acinar cells that produce it.
07/19/2007US20070166824 Manipulation of non-terminally differentiated cells using the notch pathway
07/19/2007US20070166796 Il-21 antagonists
07/19/2007US20070166795 Cytokine-like proteins
07/19/2007US20070166794 Cytokine zalpha11 ligand fusion proteins
07/19/2007US20070166793 Isolated, recombinantly produced; single protein that is dual-action catalyst that utilizes UDP-GlcA and UDP-GlcNAc to synthesize hyaluronic acid; pharmacokinetics
07/19/2007US20070166792 Increasing hemoglobin and other heme protein production in bacteria by co-expression of heme transport genes
07/19/2007US20070166791 Expanding the eukaryotic genetic code
07/19/2007US20070166790 Derivatives of magainin and methods of production thereof
07/19/2007US20070166789 polynucleotide comprising a DNA sequence that codes for a polypeptide having oxidoreductase enzyme activity, used in detection assays, gene therapy, and screening assays
07/19/2007US20070166788 Methods for production of receptor and ligand isoforms
07/19/2007US20070166787 Modulators of regulatory proteins
07/19/2007US20070166786 Protein for use in generating resistance to bactericides in cells
07/19/2007US20070166785 genetic engineered proteins having amino acid sequences coded by genes comprising the nucleic acid sequence isolated from the stomachs of cattle; proteolytic enzymes useful in the preparation of cheeses
07/19/2007US20070166784 Combination approaches for generating immune responses
07/19/2007US20070166783 using a highly inexpensive natural polysaccharide having a mannose beta -1,4-bond as the starting material, a beta -1,4-glycoside bond of mannose is formed; preparing trisaccharide moiety of the reducing terminal utilizing galactomannan, guar gum and/or mannan derivatives
07/19/2007US20070166778 Substrates and methods for assaying deubiquitinating enzymes
07/19/2007US20070166756 Polypeptides and polynucleotides encoding same
07/19/2007US20070166748 Nucleic acid which encode diacylglycerol acyltransferase family members; obesity
07/19/2007US20070166746 Human cytokine receptor
07/19/2007US20070166736 A nucleic acid encodes the polypeptide or fragment has ability to form a triple helix, form higher order collagen fibrils or fibers and provide tensile strenght or flexibility to muscle connective tissue, recognized by R34 antibody
07/19/2007US20070166719 Novel modular type II restriction endonuclease, cspci, and the use of modular endonucleases for generating endonucleases with new specificities
07/19/2007US20070166432 Amylase
07/19/2007US20070166350 Compositions and methods for promoting attachment of cells of endothelial cell lineage to medical devices
07/19/2007US20070166332 A di-chain loop region modification comprising a Clostridial toxin substrate cleavage site from a SNARE protein within the di-chain loop region that is proteolytically cleaved by the enzymatic domain of the recombinantly modified Clostridial toxin; cell expression includes single to di-chain conversion
07/19/2007US20070166318 Compositions, splice variants and methods relating to ovarian specific nucleic acids and proteins
07/19/2007US20070166314 EpA2 monoclonal antibodies and methods of use thereof
07/19/2007US20070166312 Antibody against tumor specific antigen as target
07/19/2007US20070166310 prostate cancer and benign prostatic hyperplasia; promote tissue regeneration and to facilitate wound healing
07/19/2007US20070166305 Human estrogen receptor specific immunoglobulin for diagnosis, prevention and treatment of cell proliferative disorders